Announcement

Collapse
No announcement yet.

Int J Infect Dis . Pembrolizumab in combination with tocilizumab in high-risk hospitalized COVID-19 patients (COPERNICO): A randomized proof-of-concept phase II study

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
    No photos found.
Working...
X